Avista Capital Partners III GP, L.P.

Avista Capital Partners III GP, L.P. appears in our data through filings on RVL Pharmaceuticals plc shares, published by SEC (Form 4). Over a trading history stretching from 13 January 2020 to 27 January 2023, the count stands at 3 filings.

On the market, this insider has only ever bought: 1 purchase, €5.6M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The newest entry dates from 30 January 2023: a transaction, in RVL Pharmaceuticals plc. The clock since the last published purchase (15 January 2020) now reads 2,474 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.